Novartis AG is 180.1x more valuable than Amylyx Pharmaceuticals, Inc. by market capitalization ($292.08 B vs $1.62 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | AMLX | NVS |
|---|---|---|
| Market cap | $1.62 B | $292.08 B |
| US-listed rank | #2273 | #47 |
| Revenue (latest FY) | $0.00 | - |
| Net income (latest FY) | -$144.74M | - |
| SEC filings | 403 | 947 |
Novartis AG is 180.1x more valuable than Amylyx Pharmaceuticals, Inc. by market capitalization ($292.08 B vs $1.62 B).
Full pages: Amylyx Pharmaceuticals, Inc. and Novartis AG, or browse the full rankings.